Alliance for Aging Research President and CEO Sue Peschin joined Dana Goldman, Charles Makin, and Peter Neumann to co-author “Modelling the Value of Innovative Treatments For Alzheimer’s Disease in the United States,” a study published in the Journal of Medical Economics. You can read the full study here.
The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.
